| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jacqueline S Womersley, Lauriston A Kellaway, Dan J Stein, Greg A Gerhardt, Vivienne A Russel. Effect of cocaine on striatal dopamine clearance in a rat model of developmental stress and attention-deficit/hyperactivity disorder. Stress (Amsterdam, Netherlands). vol 19. issue 1. 2016-09-22. PMID:26394534. |
though the physiological mechanisms underlying this risk are not yet clear, adhd, developmental stress and drug abuse are known to share underlying disturbances in dopaminergic neurotransmission. |
2016-09-22 |
2023-08-13 |
rat |
| Adrian L Loprest. Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies. Attention deficit and hyperactivity disorders. vol 7. issue 4. 2016-08-31. PMID:25894292. |
attention deficit hyperactivity disorder (adhd) has a complex aetiology although theories associated with disturbances in dopaminergic and noradrenergic activity are most commonly cited. |
2016-08-31 |
2023-08-13 |
Not clear |
| Rongyi Zhou, Xinmin Han, Jiaojiao Wang, Jichao Su. Baicalin may have a therapeutic effect in attention deficit hyperactivity disorder. Medical hypotheses. vol 85. issue 6. 2016-08-30. PMID:26604025. |
we hypothesize that baicalin may protect dopaminergic neurons and increase brain dopamine levels, thus serving as an effective novel treatment for adhd. |
2016-08-30 |
2023-08-13 |
Not clear |
| Rajendra D Badgaiyan, Sampada Sinha, Munawwar Sajjad, David S Wac. Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder. PloS one. vol 10. issue 9. 2016-06-01. PMID:26422146. |
by characterizing the nature of dysregulated dopamine neurotransmission in adhd, the results explain earlier findings of reduced or increased dopaminergic activity. |
2016-06-01 |
2023-08-13 |
human |
| Ming-Tao Yang, Dai-Hua Lu, Jui-Ching Chen, Wen-Mei F. Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD. Psychopharmacology. vol 232. issue 20. 2016-05-13. PMID:26228972. |
dysregulation of noradrenergic and dopaminergic systems is involved in the pathology of attention deficit hyperactivity disorder (adhd). |
2016-05-13 |
2023-08-13 |
rat |
| Radek Ptacek, George B Stefano, Simon Weissenberger, Devang Akotia, Jiri Raboch, Hana Papezova, Lucie Domkarova, Tereza Stepankova, Michal Goet. Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced. Neuropsychiatric disease and treatment. vol 12. 2016-04-04. PMID:27042070. |
interestingly, both eds and adhd rely on a common neural substrate, namely, dopaminergic signaling. |
2016-04-04 |
2023-08-13 |
Not clear |
| Maria Chiara Paolino, Alessandro Ferretti, Maria Pia Villa, Pasquale Paris. Headache and ADHD in Pediatric Age: Possible Physiopathological Links. Current pain and headache reports. vol 19. issue 7. 2016-03-16. PMID:26049768. |
dopaminergic system dysfunction, brain iron deficiency, and sleep disturbance should be considered to better understand headache and adhd overlap. |
2016-03-16 |
2023-08-13 |
Not clear |
| Emili Banerjee, Krishnadas Nandagopa. Does serotonin deficit mediate susceptibility to ADHD? Neurochemistry international. vol 82. 2015-12-15. PMID:25684070. |
studies from animal models of adhd indicate intimate interplay between 5-ht and dopaminergic neurotransmission. |
2015-12-15 |
2023-08-13 |
Not clear |
| Stefanie C Biehl, Kathrin M Gschwendtner, Anne Guhn, Laura D Müller, Susanne Reichert, Julia Heupel, Andreas Reif, Jürgen Deckert, Martin J Herrmann, Christian P Jaco. Does adult ADHD interact with COMT val (158) met genotype to influence working memory performance? Attention deficit and hyperactivity disorders. vol 7. issue 1. 2015-11-23. PMID:25007787. |
both attention-deficit/hyperactivity disorder (adhd) and catechol-o-methyltransferase (comt) genotype have been linked to altered dopaminergic transmission and possible impairment in frontal lobe functioning. |
2015-11-23 |
2023-08-13 |
Not clear |
| Dylan B Jackson, Kevin M Beave. Sibling differences in low birth weight, dopaminergic polymorphisms, and ADHD symptomatology: evidence of GxE. Psychiatry research. vol 226. issue 2-3. 2015-09-28. PMID:25704081. |
sibling differences in low birth weight, dopaminergic polymorphisms, and adhd symptomatology: evidence of gxe. |
2015-09-28 |
2023-08-13 |
Not clear |
| Dylan B Jackson, Kevin M Beave. Sibling differences in low birth weight, dopaminergic polymorphisms, and ADHD symptomatology: evidence of GxE. Psychiatry research. vol 226. issue 2-3. 2015-09-28. PMID:25704081. |
the present study addresses these limitations in prior research by examining a) whether sibling differences in low birth weight status are significantly predictive of sibling differences in behaviors symptomatic of adhd and b) whether sibling differences in dopaminergic genes interact with sibling differences in low birth weight status to predict sibling differences in adhd symptomatology. |
2015-09-28 |
2023-08-13 |
Not clear |
| Dylan B Jackson, Kevin M Beave. Sibling differences in low birth weight, dopaminergic polymorphisms, and ADHD symptomatology: evidence of GxE. Psychiatry research. vol 226. issue 2-3. 2015-09-28. PMID:25704081. |
moreover, possessing greater genetic risk on three dopaminergic genes (dat1, drd2, and drd4) relative to a sibling appears to exacerbate the link between sibling differences in birth weight and sibling differences in adhd symptomatology. |
2015-09-28 |
2023-08-13 |
Not clear |
| Yasuko Kitagishi, Akari Minami, Atsuko Nakanishi, Yasunori Ogura, Satoru Matsud. Neuron membrane trafficking and protein kinases involved in autism and ADHD. International journal of molecular sciences. vol 16. issue 2. 2015-09-25. PMID:25647412. |
attention deficit hyperactivity disorder (adhd) is documented to dopaminergic insufficiencies, which is attributed to synaptic dysfunction of dopamine transporter (dat). |
2015-09-25 |
2023-08-13 |
Not clear |
| Esther Aarts, Mieke van Holstein, Martine Hoogman, Marten Onnink, Cornelis Kan, Barbara Franke, Jan Buitelaar, Roshan Cool. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine. Behavioural pharmacology. vol 26. issue 1-2. 2015-09-03. PMID:25485641. |
we used functional genetic neuroimaging to assess the effects of dopaminergic medication and reward motivation on task-switching and striatal bold signal in 23 adults with adhd, on and off methylphenidate, and 26 healthy controls. |
2015-09-03 |
2023-08-13 |
Not clear |
| Esther Aarts, Mieke van Holstein, Martine Hoogman, Marten Onnink, Cornelis Kan, Barbara Franke, Jan Buitelaar, Roshan Cool. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine. Behavioural pharmacology. vol 26. issue 1-2. 2015-09-03. PMID:25485641. |
this was because a subgroup of patients with adhd showed markedly exaggerated effects of reward on the striatal bold signal during task-switching when they were off their dopaminergic medication. |
2015-09-03 |
2023-08-13 |
Not clear |
| Taylor F Smith, Arthur D Anastopoulos, Melanie E Garrett, Alejandro Arias-Vasquez, Barbara Franke, Robert D Oades, Edmund Sonuga-Barke, Philip Asherson, Michael Gill, Jan K Buitelaar, Joseph A Sergeant, Scott H Kollins, Stephen V Faraone, Allison Ashley-Koc. Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 165B. issue 8. 2015-08-28. PMID:25346392. |
this study investigated if genetic variants in angiogenic, dopaminergic, neurotrophic, kynurenine, and cytokine-related biological pathways moderate the relationship between birth weight and adhd symptom severity. |
2015-08-28 |
2023-08-13 |
Not clear |
| Ann Childress, Floyd R Salle. Pozanicline for the treatment of attention-deficit/hyperactivity disorder. Expert opinion on investigational drugs. vol 23. issue 11. 2015-06-15. PMID:25196198. |
medications currently used for the treatment of adhd enhance dopaminergic and/or noradrenergic transmission. |
2015-06-15 |
2023-08-13 |
Not clear |
| Blair A Johnston, Benson Mwangi, Keith Matthews, David Coghill, Kerstin Konrad, J Douglas Steel. Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification. Human brain mapping. vol 35. issue 10. 2015-05-20. PMID:24819333. |
high accuracy prediction was supported by a region of reduced white matter in the brainstem, associated with a pons volumetric reduction in adhd, adjacent to the noradrenergic locus coeruleus and dopaminergic ventral tegmental area nuclei. |
2015-05-20 |
2023-08-13 |
human |
| Blair A Johnston, Benson Mwangi, Keith Matthews, David Coghill, Kerstin Konrad, J Douglas Steel. Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification. Human brain mapping. vol 35. issue 10. 2015-05-20. PMID:24819333. |
medications used to treat adhd modify dopaminergic and noradrenergic function. |
2015-05-20 |
2023-08-13 |
human |
| Soyeon Kim, Mohamed Al-Haj, Samantha Chen, Stuart Fuller, Umesh Jain, Marisa Carrasco, Rosemary Tannoc. Colour vision in ADHD: part 1--testing the retinal dopaminergic hypothesis. Behavioral and brain functions : BBF. vol 10. 2015-04-06. PMID:25344625. |
colour vision in adhd: part 1--testing the retinal dopaminergic hypothesis. |
2015-04-06 |
2023-08-13 |
Not clear |